Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novo Nordisk Plans GLP-1 Analogue Expansion To Treat Diabetes, Obesity

Jan 31 2008

• By Carlene Olsen

Related Content

Novo Nordisk Halts Development Of AERx, Its Phase III Fast-Acting Inhaled Insulin Product

Jan 15 2008

Novo Nordisk Liraglutide Filing Planned In Q2 2008 For Diabetes

Dec 12 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window